Companies · Other Health Care

Airxpanders Inc

Palo Alto · Other Health Care

Diligence memoA one-page analyst read on Airxpanders Inc — recommendation, valuation, rhythm, risks.
$60.0M
Total raised · real
8
Rounds
5.0×
Latest step-up
Top 8%
Sector rank · raised
Series A
Latest stage · inferred · Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time)

Airxpanders Inc looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 2.48× the median modeled value of Series A Other Health Care companies in 2016–2018 (157 peers) — value vs value, same stage and era.
Dormant
  • Last raise 10.0 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Airxpanders Inc is one of 5376 Other Health Care companies tracked from Palo Alto. By capital raised it ranks among the largest (ahead of 93% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$125M$250M$375M$500MPre-Seed · 2009-03-13 Raised $752K (real) Modeled valuation $23M (est)Pre-Seed2009Series A · 2010-04-21 Raised $5.4M (real) Modeled valuation $110M (est)Series A2010Series A · 2012-01-18 Raised $11M (real) Modeled valuation $230M (est)Series A2012Series A · 2012-01-18 Raised $10M (real) Modeled valuation $208M (est)Series A2012Series A · 2013-06-04 Raised $9.9M (real) Modeled valuation $201M (est)Series A2013Series A · 2013-06-04 Raised $4.3M (real) Modeled valuation $87M (est)Series A2013Series A · 2015-02-03 Raised $3.0M (real) Modeled valuation $60M (est)Series A2015Series A · 2016-06-14 Raised $15M (real) Modeled valuation $300M (est)Series A2016+$5.4M+$11M+$10M+$9.9M+$4.3M+$3.0M+$15MCumulative $60M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$752K · 2009
Series A$5.4M · 2010no Seed on file
Series A extension$11.4M · 2012
Series A extension$10.3M · 2012
Series A extension$9.9M · 2013
Series A extension$4.3M · 2013
Series A extension$3.0M · 2015
Series A extension$14.9M · 2016

Stages are modeled from round size (public records carry no series label). No record for: Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 67%.

Modeled valuation trajectory
$300.5M
Base estimate est.
$19.1M
Conservative case
$1.6B
Upside case
$67.7M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $23.2M · 2009-03-132009Series A · modeled $110.0M · 2010-04-21Series A · modeled $229.8M · 2012-01-18Series A · modeled $208.0M · 2012-01-18Series A · modeled $200.8M · 2013-06-04Series A · modeled $86.5M · 2013-06-04Series A · modeled $60.5M · 2015-02-03Series A · modeled $300.5M · 2016-06-142016
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
6.0 yr
Elapsed time used
10.1 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
12 mo
Avg between rounds
$8.3M/yr
Capital velocity
17.3 yr
On record since
2009
First round
8
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 25× above median
This company$60.0M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 2.7× above median
This company$14.9M
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 14× above median
This company$300.5M
Sector median$22.1M

Raised more than 93% of sector peers (real $). Modeled value above 91% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #2 of 157.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0MCapital raised (log)HemoSonics, LLC · Series A Raised $24.9M · modeled $302.7M (est)Mercator Medsystems Inc · Series A Raised $20.5M · modeled $289.2M (est)Simple Contacts Inc. · Series A Raised $24.1M · modeled $285.5M (est)AVG Holdings, Inc. · Series A Raised $14.0M · modeled $282.5M (est)Avia Holdings, Llc · Series A Raised $27.9M · modeled $272.7M (est)Traditions at Rivertown Park, LLC · Series A Raised $13.5M · modeled $272.4M (est)Access Integrated Healthcare, LLC · Series A Raised $13.2M · modeled $265.8M (est)Gauss Surgical, Inc. · Series A Raised $20.5M · modeled $254.2M (est)4WEB, Inc. · Series A Raised $12.5M · modeled $252.2M (est)Iantech, Inc. · Series A Raised $12.2M · modeled $246.7M (est)AbsoluteCARE, Inc. · Series A Raised $25.7M · modeled $242.6M (est)Airxpanders Inc (this company) Raised $60.0M · modeled $300.5M (est)Airxpanders Inc
CompanyStageRaised · realValue · estvs peer med.
HemoSonics, LLCSeries A$24.9M$302.7M2.50×
Airxpanders Inc this companySeries A$60.0M$300.5M2.48×
Mercator Medsystems IncSeries A$20.5M$289.2M2.39×
Simple Contacts Inc.Series A$24.1M$285.5M2.36×
AVG Holdings, Inc.Series A$14.0M$282.5M2.33×
Avia Holdings, LlcSeries A$27.9M$272.7M2.25×
Traditions at Rivertown Park, LLCSeries A$13.5M$272.4M2.25×
Access Integrated Healthcare, LLCSeries A$13.2M$265.8M2.20×
Gauss Surgical, Inc.Series A$20.5M$254.2M2.10×
4WEB, Inc.Series A$12.5M$252.2M2.08×
Iantech, Inc.Series A$12.2M$246.7M2.04×
AbsoluteCARE, Inc.Series A$25.7M$242.6M2.00×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$752K2009-03-13$4.2M$23.2M90%
Series A$5.4M2010-04-21$24.8M$110.0M90%
Series A$11.4M2012-01-18$51.8M$229.8M90%
Series A$10.3M2012-01-18$46.9M$208.0M90%
Series A$9.9M2013-06-04$45.2M$200.8M90%
Series A$4.3M2013-06-04$19.5M$86.5M90%
Series A$3.0M2015-02-03$13.6M$60.5M90%
Series A$14.9M2016-06-14$67.7M$300.5M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$752K2009-03-13
    • First recorded raise — entered as Pre-Seed.
  2. Series A$5.4M2010-04-21
    • Raised 13 mo later, in step with the ~14 mo sector norm.
    • Round 7.2× larger than the prior — scaling up.
  3. Series A$11.4M2012-01-18
    • Raised again after 21 mo — slower than the ~14 mo sector norm.
    • Round 2.1× larger than the prior — scaling up.
  4. Series A$10.3M2012-01-18
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
  5. Series A$9.9M2013-06-04
    • Raised 17 mo later, in step with the ~14 mo sector norm.
    • Round roughly the size of the prior one.
  6. Series A$4.3M2013-06-04
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 2.3× smaller than the prior — bridge or down round.
  7. Series A$3.0M2015-02-03
    • Raised 20 mo later, in step with the ~14 mo sector norm.
    • Round 1.4× smaller than the prior — bridge or down round.
  8. Series A$14.9M2016-06-14
    • Raised 16 mo later, in step with the ~14 mo sector norm.
    • Round 5.0× larger than the prior — scaling up.
Intelligence
2017 ~Q2
Modeled next raise · ~12mo cadence
$44.7M
Modeled next size est.range $29.0M$71.5M
5.0×
Last step-up
$8.3M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Albert Cha8 other2012-01
Brigitte Smith4 other2010-04
Chris Jones4 other2009-03
Dennis Condon4 other2013-06
Tadmor Shalon4 other2009-03
Brian Clevinger3 other2009-03
Kevin Etzkorn2 other2009-03
Scott Dodson2 other2012-01
Barry Cheskin1 other2009-03
Gregory Lichtwardt2016-06
John Lai2015-02
Scott Murcray2016-06
Zita Peach2016-06
Registry & provenance

Airxpanders Inc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1387156
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Carbylan Therapeutics, Inc.Other Health CareSeries A$15.0M$80.7Mnetwork1 shared operator · same sector · same stage
Celleration IncOther Health CareSeries A$14.4M$129.7Mnetwork1 shared operator · same sector · same stage
PolyRemedy IncOther Health CareSeries A$13.7M$10.9Mnetwork1 shared operator · same sector · same stage
Medley Health, Inc.Other Health CareSeries A$13.0M$30.3Mnetwork1 shared operator · same sector · same stage
Neomend IncOther Health CareSeries B$48.9M$221.5Mnetwork1 shared operator · same sector
Cardiovascular Systems IncOther Health CareSeries A$58.5M$272.4Msame sector · same stage
Wellfount, CorpOther Health CareSeries A$49.4M$240.5Msame sector · same stage
Nanostim IncOther Health CareSeries A$48.0M$191.7Msame sector · same stage
Frequently asked
How much funding has Airxpanders Inc raised?
Airxpanders Inc has raised approximately $60.0M in disclosed capital across 8 recorded financing rounds, aggregated from public filings.
What is Airxpanders Inc's estimated valuation?
Provath's modeled valuation for Airxpanders Inc is approximately $300.5M (modeled range $19.1M–$1.6B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Airxpanders Inc at?
Airxpanders Inc's latest modeled financing stage is Series A. Its most recent recorded round closed around Tue Jun 14.
What does Airxpanders Inc do and where is it based?
Airxpanders Inc operates in the Other Health Care sector, based in Palo Alto.
Explore related

See where Airxpanders Inc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Airxpanders Inc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.